Authored by Chris McDermott, APRN, practicing with autonomous authority in Florida | Intercoastal Health, Florida
Insulin resistance is a silent but significant disruptor of metabolic health. Often developing insidiously over years, this condition is a precursor to a host of chronic illnesses, including Type 2 Diabetes, cardiovascular disease, and polycystic ovary syndrome (PCOS). At Intercoastal Health, we utilize a functional medicine lens—centered around identifying root causes and addressing system imbalances—to detect, manage, and reverse insulin resistance before it progresses into more serious disease states.
Insulin is a critical hormone produced by the pancreas, responsible for helping cells absorb glucose from the bloodstream to use for energy or storage. In insulin resistance, the cells—particularly in the liver, muscle, and fat—become less responsive to insulin. This dysfunction forces the pancreas to produce more insulin to maintain normal blood glucose levels. Over time, this compensatory mechanism becomes overwhelmed, leading to hyperinsulinemia, impaired glucose regulation, and eventually, Type 2 Diabetes Mellitus.
From a functional medicine standpoint, insulin resistance reflects deeper metabolic imbalances influenced by lifestyle, diet, hormones, inflammation, stress, and environmental exposures.
Insulin resistance can remain asymptomatic for years. However, early and progressive symptoms may include:
At Intercoastal Health, we use a comprehensive, biomarker-driven approach to detect dysfunction early—even before conventional labs flag abnormalities.
Each laboratory value is interpreted through functional medicine standards, evaluating optimal—not just “normal”—ranges.
Insulin resistance is multifactorial. Addressing root contributors allows meaningful, long-lasting improvements.
Unchecked insulin resistance heightens risk for:
Early functional intervention can slow or prevent progression.
Biomarker | Clinical Range | Functional/Optimal Range | Clinical Implication |
Fasting Glucose | 65–99 mg/dL | 75–86 mg/dL | Elevated in progressing insulin resistance |
Fasting Insulin | 2.0–19.6 µIU/mL | 2.0–5.0 µIU/mL | High levels reflect compensatory hyperinsulinemia |
HbA1c | <5.7% | 4.6–5.3% | Later-stage glucose dysregulation |
Triglycerides | <150 mg/dL | 70–80 mg/dL | Elevated in metabolic dysfunction |
HDL Cholesterol | >39.9 mg/dL | >55 mg/dL (men), >60 mg/dL (women) | Low HDL suggests insulin resistance |
HOMA2-IR | <1.0 | 0.5–0.75 | Key functional marker for insulin resistance |
Factors that can affect lab results:
Medication management should be coordinated with licensed healthcare providers.
At Intercoastal Health, we help patients understand that insulin resistance is reversible through consistent, root-cause-focused interventions—not just pharmaceutical management.
Insulin resistance is a pivotal factor in chronic disease development—but it is modifiable. A functional medicine practitioner at Intercoastal Health offers an advanced evaluation model rooted in biomarker analysis, lifestyle modification, and nutritional strategies to promote metabolic resilience.
Samuel, V. T., & Shulman, G. I. (2018). Insulin resistance: mechanisms, syndromes, and implications. The New England Journal of Medicine, 354(24), 2667-2679. https://pubmed.ncbi.nlm.nih.gov/29939616/
Reutrakul, S., & Mokhlesi, B. (2016). Treatment approach to patients with severe insulin resistance. Current Diabetes Reports, 16(1), 1-10. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4833480/
Cignarelli, A., Genchi, V. A., & Giorgino, F. (2012). Insulin resistance: Is it time for primary prevention? International Journal of Endocrinology, 2012, Article ID 921675. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3262393/
Sesti, G., & Federici, M. (2022). Recent advances in the treatment of insulin resistance targeting molecular pathways. Frontiers in Endocrinology, 13, 899123. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9029454/
In conclusion, a comprehensive evaluation by a functional medicine practitioner in Florida facilitates identification of cellular and metabolic imbalances underlying insulin resistance. By integrating evidence-based functional strategies with medical weight loss and longevity medicine programs, we empower patients to optimize their metabolic health and prevent disease progression. Call (904) 799‑2531 or schedule online to begin your personalized metabolic health journey today.
Ready to take the next step in optimizing your health? Contact us to schedule a comprehensive functional medicine evaluation centered on whole-person care. We offer convenient in-person and telemedicine appointments. Our team is available to assist with scheduling and to ensure you receive the support and care you need.
Comprehensive care with a whole person approach, specializing in injury management, wellness, and longevity.
hello@intercoastalhealth.com
4320 Deerwood Lake Parkway
Suite 327
Jacksonville, Florida 32216
Disclaimer: The content on this website is for informational purposes only and does not constitute medical advice or replace professional medical care, diagnosis, or treatment. Eligibility for medical treatments will be determined by your healthcare provider, who will exercise discretion regarding your treatment plan. All images are intended for educational purposes only. Statements made on this website have not been evaluated by the Food and Drug Administration. Always consult your healthcare provider before initiating or discontinuing any treatment.
Intercoastal Health – Copyright © 2025 All Rights Reserved.